Skip to main content

Table 3 Exponentiated coefficients; 95% confidence intervals in brackets of the physiotherapy related treatment modalities

From: Gender differences in treatments and interventions received by children and adolescents with cerebral palsy

Outcome variables (yes/no)

Independent variables (reference group)

Use of spinal brace

Received BTX- A since last assessment

Has ITB treatment †

Oral spasticity reducing medication

Undergone SDR surgery

Assistive device for standing

Physiotherapy treatment since last assessment

Gender (female)

1.54*

0.81

0.49

0.96

0.49*

1.13

1.16

[1.07,2.22]

[0.64,1.02]

[0.22,1.08]

[0.65,1.43]

[0.25,0.94]

[0.80,1.60]

[0.93,1.43]

Place of birth (outside of the Nordic countries)

1.49

0.70

0.27*

0.78

0.56

0.66

0.94

[0.87,2.55]

[0.47,1.05]

[0.074,0.98]

[0.43,1.43]

[0.19,1.71]

[0.38,1.15]

[0.64,1.37]

Gender X place of birth

0.20***

1.48

0.85

0.77

1.08

0.66

0.64

[0.079,0.53]

[0.81,2.70]

[0.068,10.6]

[0.29,2.02]

[0.16,7.20]

[0.30,1.50]

[0.37,1.11]

Age

1.05*

0.98

1.28***

1.05*

1.04

0.10

0.90***

[1.01,1.09]

[0.96,1.00]

[1.17,1.39]

[1.01,1.09]

[0.98,1.11]

[0.96,1.03]

[0.88,0.93]

GMFCS (GMFCS I)

 II

2.77

1.17

 

3.57**

2.75*

15.92***

2.31***

[0.69,11.1]

[0.86,1.58]

 

[1.46,8.76]

[1.12,6.76]

[5.48,46.2]

[1.77,3.01]

 III

9.38***

1.40

 

4.36**

23.23***

136.2***

4.40***

[2.78,31.68]

[0.99,2.00]

 

[1.72,11.07]

[11.0,49.05]

[49.05,378.4]

[2.92,6.61]

 IV

76.56***

1.353

1

13.10***

4.80**

1001.0***

8.22***

[27.19,215.5]

[0.97,1.90]

[1]

[5.86,29.32]

[1.85,12.50]

[355.72816.9]

[5.11,13.24]

 V

222.6***

1.030

6.53***

37.29***

0.76

1730.4***

8.35***

[79.16,625.7]

[0.71,1.50]

[3.11,13.68]

[16.93,82.14]

[0.10,6.02]

[594.75035.1]

[4.90,14.24]

 Spasticity score

1.00

1.03***

1.00

1.03***

0.95***

1.02***

1.02***

[0.99,1.01]

[1.02,1.04]

[0.98,1.02]

[1.02,1.04]

[0.93,0.97]

[1.01,1.03]

[1.01,1.03]

  1. Relationship, presented as odds ratio with 95% confidence intervals in brackets, of the physiotherapy reported outcome variables and gender, adjusted for place of birth, age, Gross Motor Function Classification System (GMFCS) levels and spasticity score. BTX-A- Botulinum Toxin- A, ITB- Intrathecal Baclofen, SDR- Selective Dorsal Rhizotomy.
  2. † For intrathecal baclofen, only GMFCS IV and V were analyzed with IV as the reference.
  3. .* p < 0.05, ** p < 0.01, *** p < 0.001